Insignis Therapeutics Inc.
New Filing
CIK: 0001981826·Other·DELAWARE·Filed: Aug 5, 2026
Total Offering
$8,500,000
Amount Sold
$5,999,714
Investors
4
First Sale
Jun 11, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Mingbao Zhang |
Company
SEC Filing
0001493152-26-036132
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free